Top 20 kamada.com competitors & alternatives
[kamada - high quality pharmaceuticals - kamada pharmaceuticals Now more than ever, each life is unique. We are proud to lead the efforts for the development of an immunoglobulin against COVID-19 → read more...]
kamada.com competitors and alternatives
Top 20 kamada.com competitors and alternatives are ranked by similar search terms, traffic and worth.
kamada.com's top 5 competitors are: arrowheadpharma.com with 195 daily traffic and 72,400 estimated worth, prolastin.com with 0 daily traffic and 15,600 estimated worth, alpha1.org with 119 daily traffic and 14,000 estimated worth, alpha-1.com with 0 daily traffic and 13,200 estimated worth, alpha1induction.com with 0 daily traffic and 11,900 estimated worth.
arrowheadpharma.com
Arrowhead Pharmaceuticals | Target the Gene Silence the Disease
Discover Arrowhead Pharmaceuticals, a leader in developing RNA interference (RNAi) medicine for serious diseases. Explore our pipeline, research, and innovations in targeted therapies.
Daily Traffic: 195
Website Worth: $ 72,400
prolastin.com
PROLASTIN-C
PROLASTIN-C, The #1 prescribed augmentation therapy in the US for people with alpha 1 antitrypsin (AAT) deficiency
Daily Traffic: 0
Website Worth: $ 15,600
alpha1.org
alpha-1 foundation: support & awareness
discover resources, research, and community support for alpha-1 antitrypsin deficiency. join the mission to raise awareness and find a cure.
Daily Traffic: 119
Website Worth: $ 14,000
thealpha-1project.com
thealpha-1project.com is Coming Soon!
The Alpha-1 Project (TAP) is a wholly-owned for profit subsidiary of the Alpha-1 Foundation. TAP will focus funding into highly promising drug therapies or devices in the translational research or clinical trial stage of development to speed the commercialization of these therapies.
Daily Traffic: 0
Website Worth: $ 8,900
alpha1.ie
Alpha1 - Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which can cause lung, liver, and skin disease.
Alpha1 - Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which can cause lung, liver, and skin disease.
Daily Traffic: 0
Website Worth: $ 5,100
fimi.co.il
FIMI Opportunity Funds - Home
FIMI is the leading private equity firm in Israel with a track record of success spanning over 20 years. FIMI has raised six private equity funds with more than $3 billion in aggregate capital commitments.
Daily Traffic: 50
Website Worth: $ 700
zemaira.com
ZEMAIRA®: Treatment for Alpha1-Antitrypsin Deficiency | Patient Homepage
Alpha1-Proteinase Inhibitor (Human), ZEMAIRA® is indicated to raise the plasma level of alpha1-proteinase inhibitor (A1-PI) in patients with A1-PI deficiency and related emphysema.
Daily Traffic: 0
Website Worth: $ 0
kedrion.us
Kedrion Biopharma - Keep Life Flowing - kedrion.us
Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies.
Daily Traffic: 0
Website Worth: $ 0
irishthoracicsociety.com
Home - Irish Thoracic Society
About The ITS The ITS was formed to support education and research into respiratory disease and its management on the island of Ireland. It also promotes awareness amongst the public and relevant authorities of related public health issues including smoking, pollution and occupational factors.
Daily Traffic: 0
Website Worth: $ 0
alpha1-deutschland.org
Alpha1 Deutschland e.V. - Alles zum Alpha-1-Antitrypsin-Mangel
Offizieller Auftritt von Alpha1 Deutschland. Hier finden Sie Informationen zum Alpha-1-Antitrypsinmangel: Selbsthilfegruppen, Alltagstipps und Vieles mehr.
Daily Traffic: 0
Website Worth: $ 0
resphealth.org.au
Home - Institute for Respiratory Health
The Institute for Respiratory Health is charitable organisation and Australia's only integrated scientific and clinical research institute dedicated specifically to investigating respiratory disease.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like kamada.com